Calcitonin Gene-Related Peptides

Handbook of Biologically Active Peptides

Volumn , Issue , 2006, Pages 1181-1186

  Tam, Christina W L ^a   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861646404     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369442-3/50165-3     Document Type: Chapter

References (59)

1. Aiyar N, Daines RA, Disa J, Chambers PA, Sauermelch CF, Quiniou M, et al. Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J Pharmacol Exp Ther 2001, 296(3):768-775.
2. Alevizaki M, Shiraishi A, Rassool FV, Ferrier GJ, MacIntyre I, Legon S The calcitonin-like sequence of the beta CGRP gene. FEBS Lett 1986, 206(1):47-52.
3. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982, 298(5871):240-244.
4. Bell D, McDermott BJ Calcitonin gene-related peptide in the cardiovascular system: Characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 1996, 48(2):253-288.
5. Brain SD, Grant AD Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 2004, 84(3):903-934.
6. Brain SD, Williams TJ Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 1985, 86(4):855-860.
7. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I Calcitonin gene-related peptide is a potent vasodilator. Nature 1985, 313(5997):54-56.
8. Bunker CB, Goldsmith PC, Leslie TA, Hayes N, Foreman JC, Dowd PM Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon. Br J Dermatol 1996, 134(3):399-406.
9. Bunker CB, Terenghi G, Springall DR, Polak JM, Dowd PM Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon. Lancet 1990, 336(8730):1530-1533.
10. Chiba T, Yamaguchi A, Yamatani T, Nakamura A, Morishita T, Inui T, et al. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 1989, 256(2):E331-E335. Pt 1.
11. Chin SY, Hall JM, Brain SD, Morton IK Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP1 receptors. J Pharmacol Exp Ther 1994, 269(3):989-992.
12. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999, 56(1):235-242.
13. Chu DQ, Choy M, Foster P, Cao T, Brain SD A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin (13-52) to modulate microvascular but not thermal hyperalgesia responses. Br J Pharmacol 2000, 130(7):1589-1596.
14. Cooper GJ, Day AJ, Willis AC, Roberts AN, Reid KB, Leighton B Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim Biophys Acta 1989, 1014(3):247-258.
15. Dennis T, Fournier A, Cadieux A, Pomerleau F, Jolicoeur FB, St Pierre S, et al. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 1990, 254(1):123-128.
16. Dennis T, Fournier A, St Pierre S, Quirion R Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther 1989, 251(2):718-725.
17. Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 2000, 129(3):420-423.
18. Dumont Y, Fournier A, St Pierre S, Quirion R A potent and selective CGRP2 agonist, [Cys(Et) 2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays. Can J Physiol Pharmacol 1997, 75(6):671-676.
19. Edvinsson L, Sams A, Jansen-Olesen I, Tajti J, Kane SA, Rutledge RZ, et al. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 2001, 415(1):39-44.
20. Eguchi S, Hirata Y, Iwasaki H, Sato K, Watanabe TX, Inui T, et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 1994, 135(6):2454-2458.
21. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000, 275(40):31438-31443.
22. Gennari C, Fischer JA Cardiovascular action of calcitonin gene-related peptide in humans. Calcif Tissue Int 1985, 37(6):581-584.
23. Girgis SI, Macdonald DW, Stevenson JC, Bevis PJ, Lynch C, Wimalawansa SJ, et al. Calcitonin gene-related peptide: Potent vasodilator and major product of calcitonin gene. Lancet 1985, 2(8445):14-16.
24. Goadsby PJ, Edvinsson L The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33(1):48-56.
25. Goadsby PJ, Edvinsson L, Ekman R Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28(2):183-187.
26. Hagner S, Haberberger RV, Overkamp D, Hoffmann R, Voigt KH, McGregor GP Expression and distribution of calcitonin receptor-like receptor in human hairy skin. Peptides 2002, 23(1):109-116.
27. Hagner S, Stahl U, Knoblauch B, McGregor GP, Lang RE Calcitonin receptor-like receptor: Identification and distribution in human peripheral tissues 810. Cell Tissue Res 2002, 310(1):41-50.
28. Hall JM, Siney L, Lippton H, Hyman A, Kang-Chang J, Brain SD Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster. Br J Pharmacol 1995, 114(3):592-597.
29. Hay DL, Conner AC, Howitt SG, Takhshid MA, Simms J, Mahmoud K, et al. The pharmacology of CGRP-responsive receptors in cultured and transfected cells. Peptides 2004, 25(11):2019-2026.
30. Hay DL, Smith DM Knockouts and transgenics confirm the importance of adrenomedullin in the vasculature. Trends Pharmacol Sci 2001, 22(2):57-59.
31. Haynes JM, Cooper ME Adrenomedullin and calcitonin generelated peptide in the rat isolated kidney and in the anaesthetised rat: in vitro and in vivo effects. Eur J Pharmacol 1995, 280(1):91-94.
32. Herrick AL Treatment of Raynaud's phenomenon: new insights and developments. Curr Rheumatol Rep 2003, 5(2):168-174.
33. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocyto. Biochem Biophys Res Commun 1993, 192(2):553-560.
34. Kjartansson J, Dalsgaard CJ Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat. Eur J Pharmacol 1987, 142(3):355-358.
35. Kraenzlin ME, Ch'ng JL, Mulderry PK, Ghatei MA, Bloom SR Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones. Regul Pept 1985, 10(2-3):189-197.
36. Lang MG, Paterno R, Faraci FM, Heistad DD Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles. Stroke 1997, 28(1):181-185.
37. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J CGRP may play a causative role in migraine 818. Cephalalgia 2002, 22(1):54-61.
38. Lechleitner P, Genser N, Mair J, Dienstl A, Haring C, Wiedermann CJ, et al. Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction. Am Heart J 1992, 124(6):1433-1439.
39. Lundberg JM, Franco-Cereceda A, Hua X, Hokfelt T, Fischer JA Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 1985, 108(3):315-319.
40. Mallee JJ, Salvatore CA, LeBourdelles B, Oliver KR, Longmore J, Koblan KS, et al. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 2002, 277(16):14294-14298.
41. Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A, Asada Y Immunohistological localization and possible functions of adrenomedullin. Hypertens Res 2003, 26(Suppl):S33-S40.
42. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393(6683):333-339.
43. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: A pharmacokinetic study. J Clin Endocrinol Metab 1997, 82(1):95-100.
44. Moreno MJ, Terron JA, Stanimirovic DB, Doods H, Hamel E Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture. Neuropharmacology 2002, 42(2):270-280.
45. Morris HR, Panico M, Etienne T, Tippins J, Girgis SI, MacIntyre I Isolation and characterization of human calcitonin generelated peptide. Nature 1984, 308(5961):746-748.
46. Mulderry PK, Ghatei MA, Spokes RA, Jones PM, Pierson AM, Hamid QA, et al. Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 1988, 25(1):195-205.
47. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004, 350(II):1104-1110.
48. Poyner D Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol Sci 1995, 16(12):424-428.
49. Poyner D, Marshall I CGRP receptors: beyond the CGRP(1)-CGRP (2) subdivision?. Trends Pharmacol Sci 2001, 22(5):223.
50. Rink TJ, Beaumont K, Koda J, Young A Structure and biology of amylin. Trends Pharmacol Sci 1993, 14(4):113-118.
51. Shawket S, Dickerson C, Hazleman B, Brown MJ Selective suprasensitivity to calcitonin-gene-related peptide in the hands in Raynaud's phenomenon. Lancet 1989, 2(8676):1354-1357.
52. Steenbergh PH, Hoppener JW, Zandberg J, Visser A, Lips CJ, Jansz HS Structure and expression of the human calcitonin/CGRP genes 547. FEBS Lett 1986, 209(1):97-103.
53. Storer RJ, Akerman S, Goadsby PJ Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004, 142(7):1171-1181.
54. Tam C, Brain SD The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: A study using in vivo and in vitro assays in the mouse. J Mol Neurosci 2004, 22(1-2):117-124.
55. +) channels. Am J Physiol Heart Circ Physiol 2000, 279(6):H2620-H2626.
56. Tomlinson AE, Poyner DR Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens. Br J Pharmacol 1996, 117(6):1362-1368.
57. van Rossum D, Hanisch UK, Quirion R Neuroanatomical localization, pharmacological characterization and function of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 1997, 21(5):649-678.
58. Westermark P, Wernstedt C, Wilander E, Sletten K A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986, 140(3):827-831.
59. Wu D, Eberlcin W, Rudolf K, Engel W, Hallermayer G, Doods H Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: Evidence for a [Cys(Et) (2, 7)]hCGRP-preferring receptor. Eur J Pharmacol 2000, 400(2-3):313-319.